Summary of Significant Accounting Policies (Details)	3 Months Ended						9 Months Ended			12 Months Ended
	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Sep. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Sep. 30, 2022 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2024 CNY (¥)	Mar. 31, 2023 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)
Summary of Significant Accounting Policies [Line Items]
Cash	$ 1,883,261						$ 1,883,261			$ 1,136,562
Working capital										(733,781)
Stockholders’ deficit	420,125	$ (87,726)	$ (277,059)	$ (1,970,276)	$ (1,491,574)	$ (1,273,814)	420,125		$ (1,970,276)	(570,655)	$ (1,022,339)
Net income(loss)	$ 517,969	$ 182,828	$ 294,744	$ (471,308)	$ (176,160)	$ (315,432)	995,541		$ (962,900)	21,085	$ (7,563,565)
Working capital							$ 94,687
Assets liabilities and net income or loss percent	100.00%						100.00%
Insurance coverage							$ 69,000	¥ 500,000
Cash in excess of the insured amount	$ 1,170,932						$ 1,170,932			606,483
Commission revenue, percentage	94.30%			10.00%			94.30%		10.00%
Cost of revenue percentage							10.00%	10.00%	10.00%
Number of operating segment							1	1
Sale return and allowance related to healthcare product							$ 891			15,406
Sales return percentage							1.14%	1.14%	1.30%
Advertising and promotion costs							$ 2,667,233		$ 539,836
Sales Returns and Allowances [Member]
Summary of Significant Accounting Policies [Line Items]
Sale return and allowance related to healthcare product							$ 0			$ 229
Sales return percentage							0.00%	0.00%	1.77%